Safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving breast cancer resistant protein (BCRP) substrate chemotherapy agents Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Schwartzberg, L
  • Jordan, K
  • Rapoport, BL
  • Schnadig, I
  • Chasen, Martin
  • Arora, S
  • Barbour, S
  • Powers, D
  • Navari, R

publication date

  • October 2016